Endometriosis

In a recent study, similar preterm birth rates were reported between patients with endometriosis and those without endometriosis.

Recent research highlights a potential connection between dietary vitamin B6 intake and the development of endometriosis, suggesting a role for diet in managing the condition.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

In a recent pilot trial, endometriosis-related visual-analog scale and quality-of-life scores were improved during anakinra treatment cycles vs placebo cycles.

A recent study suggests that postoperative endometriosis patients experience improved quality of life through hormone therapies guided by optimizing treatment based on individual hormonal receptor profiles.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Women with ovarian endometriomas or deep infiltrating endometriosis face a significantly higher risk of ovarian cancer, highlighting the need for increased awareness and research into these associations.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Serac Healthcare’s 99mTc-maraciclatide, a new radio-labelled tracer, gains FDA Fast Track Designation for its potential to improve non-invasive diagnosis of superficial peritoneal endometriosis in patients aged 16 and older.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A study revealed that women with endometriosis are significantly more likely to develop mental health issues, including depression and anxiety.

Experts recommend early referral to specialized centers for adolescents with dysmenorrhea to ensure timely diagnosis and treatment of potential endometriosis, preventing disease progression and preserving fertility.

A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.

A recent study unveiled the sustained safety and efficacy of relugolix combination therapy over 2 years.

A recent study revealed that women with endometriosis not only face a mean delay of 7 to 11 years in diagnosis but also suffer from increased menstrual, mental health, and other pain symptoms, impacting their overall well-being and quality of life.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Findings and significance for gynecologic surgeons.

Steven R. Goldstein, MD, discusses holes in clinicians' understanding of the endometrium, and how these knowledge gaps can be remedied.

In a recent study, women with a history of dysmenorrhea were at a significantly increased risk of endometriosis.

In a recent study, a lower pain-related quality of life was found in patients with preoperative pelvic pain conditions after surgery.

In a recent study, providers were more likely to recommend combined hormone replacement therapy (HRT) than estrogen-only HRT in patients with severe endometriosis because of recurrence risks from estrogen-only HRT.

Reductions in symptom incidence and severity from uterine fibroids and endometriosis have been observed in patients receiving relugolix combination therapy.

In a recent study, the Deep Pelvic Endometriosis Index accurately predicted operating and hospital stay length, along with postoperative complications, in patients with deep pelvic endometriosis.

Pain mechanisms are multifactorial, complex, and still poorly understood.

To close out Endometriosis Awareness Month in March, Rachel Cullifer, MD, discusses clinical pearls for diagnosis and treatment, as well as some common misconceptions about endometriosis.